Adhd medication names
Pro Research Analysisby 
Searched over 200M research papers
ADHD Medication Names: An Overview
Introduction to ADHD Medications
Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The treatment of ADHD often involves a combination of pharmacological and non-pharmacological interventions. This article provides an overview of the various medications used to treat ADHD, focusing on both stimulant and non-stimulant options.
Stimulant Medications for ADHD
Methylphenidate
Methylphenidate is one of the most commonly prescribed stimulant medications for ADHD. It is available in various formulations, including immediate-release and extended-release versions. Studies have shown that methylphenidate can improve ADHD symptoms and general behavior in children and adolescents, although it may be associated with non-serious adverse events such as sleep problems and decreased appetite 25. Extended-release formulations of methylphenidate are also used in adults, showing improvements in ADHD symptoms but with a risk of adverse effects .
Amphetamines
Amphetamines are another class of stimulant medications used to treat ADHD. This group includes dexamphetamine, lisdexamfetamine, and mixed amphetamine salts. These medications have been shown to reduce core ADHD symptoms in children and adolescents, but they are also associated with adverse events such as decreased appetite, insomnia, and abdominal pain 46. Despite their efficacy, the quality of evidence supporting their use varies, and there is a need for longer-term studies to better understand their safety profile .
Non-Stimulant Medications for ADHD
Atomoxetine
Atomoxetine is a selective norepinephrine reuptake inhibitor and is one of the primary non-stimulant medications used for ADHD. It has been shown to be effective in managing ADHD symptoms, although it may cause increases in blood pressure and heart rate . Atomoxetine is often considered for patients who do not respond well to stimulant medications or who experience significant side effects from stimulants 13.
Alpha-2 Adrenergic Agonists
Guanfacine and clonidine are alpha-2 adrenergic receptor agonists used as non-stimulant options for ADHD treatment. These medications can help manage symptoms of ADHD, particularly in children and adolescents. They are generally well-tolerated, but common side effects include somnolence and potential cardiovascular effects 19.
Emerging and Alternative Treatments
New Pharmacological Agents
Recent research has explored new pharmacological agents for ADHD treatment. Emerging drugs such as viloxazine and dasotraline show promise as potential treatments, with ongoing clinical trials aimed at establishing their efficacy and safety . Additionally, medications like amantadine and tipepidine are being investigated for their potential to enhance cognitive functions and manage hyperactivity/impulsivity in children .
Non-Pharmacological Interventions
Non-pharmacological treatments, including behavioral therapies, social skills training, and physical activity interventions, are also widely studied and used in managing ADHD. These interventions can be effective, particularly when combined with pharmacological treatments, providing a comprehensive approach to ADHD management .
Conclusion
The treatment of ADHD involves a variety of pharmacological options, including both stimulant and non-stimulant medications. Methylphenidate and amphetamines are the most commonly used stimulants, while atomoxetine and alpha-2 adrenergic agonists serve as key non-stimulant options. Emerging drugs and non-pharmacological interventions continue to expand the arsenal of treatments available for ADHD, offering hope for improved management of this complex disorder. Regular monitoring and individualized treatment plans are essential to optimize outcomes and minimize adverse effects.
Sources and full results
Most relevant research papers on this topic